PropertyValue
?:abstract
  • Neuroendocrine hyperplasia of infancy (NEHI) is an interstitial lung disease (ILD) of unknown etiology, which develops in infancy and manifests as persistent tachypnea Objective of the research: to summarize results of observations of patients with NEHI, including during the pandemic of a new coronavirus infectious disease (COVID-19) Materials and methods: clinical and follow-up observation, laboratory and instrumental examination, including lung biopsy, 52 children with NEHI aged from 21 days to 10 years Results: NEHI more often affects boys in the first 6 months of life;can be diagnosed on the basis of pediatric ILD-syndrome detection;specific CT signs, lung biopsy It is characterized by undulating course with increased respiratory failurec aused by acute respiratory viral infections, COVID-19;half of the patients need oxygen therapy
is ?:annotates of
?:creator
?:journal
  • Pediatriya_-_Zhurnal_im_G.N._Speranskogo
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Issues of diagnosis and management of patients with neuroendocrine cell hyperplasia of infancy
?:type
?:who_covidence_id
  • #731059
?:year
  • 2020

Metadata

Anon_0  
expand all